Zenas BioPharma LLC Deal History & Licensing Activity
Zenas BioPharma LLC is a life sciences. Over the past three years, Zenas BioPharma LLC has been involved in 2 licensing and acquisition transactions, with a primary focus on Small Molecules (2 deals). The company currently has 7 active clinical trials, primarily in Immunology.
Deals (12mo)
1
Active Trials
7
Top Modality
Small Molecules
Focus Area
Immunology
Zenas BioPharma LLC Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Zenas BioPharma LLC in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| orelabrutinib | Zenas BioPharma | Small Molecules | Phase 2 | license | Oct 2025 |
Zenas BioPharma LLC Pipeline Focus
Therapeutic areas and modalities where Zenas BioPharma LLC is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Zenas BioPharma LLC Clinical Pipeline
Zenas BioPharma LLC has 7 active clinical trials across 3 development phases.
1
Phase 1
2
Phase 2
4
Phase 3
See How Your Asset Matches Zenas BioPharma LLC's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Immunology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Immunology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for immunology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About Zenas BioPharma LLC Licensing & Deal Activity
Zenas BioPharma LLC is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Zenas BioPharma LLC ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Zenas BioPharma LLC include Immunology (3 deals and trials), CNS Disorders (3 deals and trials), and Autoimmune (3 deals and trials). In terms of modality, Zenas BioPharma LLC has shown particular interest in small molecules, antibodies.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Zenas BioPharma LLC and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Zenas BioPharma LLC's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.